New Platform Turns Protein Loss Into a Signal for Drug Discovery

Stanford researchers have developed a platform called ratiometric transcriptional activation (RTA) that converts subtle protein loss inside living cells into an amplified signal, improving detection of protein degradation. This can accelerate discovery of targeted protein degraders, a new class of drugs that eliminate disease-causing proteins by promoting their destruction rather than blocking them.

This Wire brief sits within Fusion42's coverage of Drug Discovery.